SCD and cancer: The finding of low levels of cyclin D1 detected in cancer cells undergoing a blockade of SCD1 [23] suggests a direct link between reduced Akt activity with a subsequent activation of GSK3-β and the deregulation of cell cycle progression observed in these cells.